CD8A and breast cancer: Our findings of increased CD8+ T cells and delayed progression of established TNBC brain metastases by ISIM treatment of mammary tumors are in line with our recent data in mouse models bearing bilateral mammary tumors29, and further demonstrated that this can occur in metastatic lesions that cross the blood–brain-barrier.